This Special Notice opportunity from New York was posted on March 19, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
81626Y0808-Purchase of Sole Source items from Cepheid
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The New York City Department of Health and Mental Hygiene intends to enter into a six-year agreement with Cepheid for the direct purchase of GeneXpert systems and Xpert reagents. This procurement includes assay kits, equipment, service, maintenance, and necessary supplies to be used by the Public Health Laboratory and Sexual Health Clinics. These tools are essential for the detection and identification of various pathogens, including COVID-19, tuberculosis, mpox, influenza, and various sexually transmitted infections. The agency has identified Cepheid as the sole source provider because the Xpert reagent test cartridges are specifically designed for use only with Cepheid instruments. Interested firms that believe they can legally provide these goods must submit an Expression of Interest under EPIN 81626Y0808 by March 30, 2026, at 2:00 P.M.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
Pursuant to Section 3-05 of the New York City Procurement Policy Board Rules, the Department of Health and Mental Hygiene (DOHMH) intends to enter into negotiations for a six-year agreement with Cepheid for the direct purchase of Xpert® reagents and GeneXpert® systems- assay kits, reagents, equipment (including service and maintenance), and other needed supplies. These products will be utilized by DOHMH's Public Health Laboratory (PHL) and Sexual Health Clinics for clinical and environmental testing for the detection and identification of carbapenemase, Sexually Transmitted Infections (STIs) and other emerging bacteria, pathogens and viruses, such as Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), COVID-19, mpox, influenza, bird flu, norovirus, trichomonas, tuberculosis and multidrug-resistant superbugs.
DOHMH has determined that Cepheid is the sole provider for the required assay kits, reagents, and equipment (including service and maintenance). Cepheid is the sole manufacturer of Xpert® reagents, and GeneXpert® systems. Xpert® reagent test cartridges are designed and manufactured to only be used with Cepheids instruments.
Any firm that believes it can legally provide these goods is invited to submit an Expression of Interest directly to this RFI- EPIN 81626Y0808 no later than 3/30/2026 by 2:00 P.M.
If you need additional assistance with PASSPort, please contact the MOCS Service Desk at https://mocssupport.atlassian.net/servicedesk/customer/portal/8
PIN: 81626Y0808
More opportunities from New York → Health And Mental Hygiene
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS